Clinical trial Recruiting at 1 site Observational Ages 18 and up

Improving transition of congenital heart disease care from pediatric to adult services

Official title: Transition and Transfer of Congenital Heart Disease Care From Pediatrics to Adulthood.

Run by Ottawa Heart Institute Research Corporation · NCT07585175 · Data updated 2026-11-12

This program will try a multi-step transfer process to reduce health declines in people with congenital heart disease who are waiting to see an adult specialist.

More Congenital Heart Disease (CHD) trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment200 (estimated)
SponsorOttawa Heart Institute Research Corporation
Academic / other
Locations1 site (Ottawa, Ontario)
StatusRecruiting
StartedJune 1, 2024
Main results expectedDecember 31, 2026
Study endsDecember 31, 2026
Registry record updatedJuly 2, 2026
Trial IDNCT07585175 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

New patients with congenital heart disease who have been referred from pediatric services or the community and are on the adult ACHD wait list are ideal candidates.

Probably not a fit

Patients already established in continuous adult ACHD follow-up or those who require immediate in-person cardiology care are unlikely to benefit from this waitlist-focused program.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This prospective quality-improvement program will offer a structured, multi-pronged transfer pathway to all new ACHD patients on the adult wait list at the University of Ottawa Heart Institute. Patients are enrolled in staggered groups so the first 50 receive an ACHD nurse check-in and a diagnosis summary, the next 50 also receive an ACHD education day, and later patients additionally receive a combined pediatric-ACHD handover video call. Clinical outcomes for all participants will be tracked by chart review and consenting patients will complete voluntary patient-reported outcome surveys conducted by phone or Zoom. The program is designed to detect early deterioration and provide additional support during the typical wait for adult ACHD assessment.

Why it matters

Potential benefit: If successful, the program could reduce gaps in care and lower the risk of clinical deterioration while patients wait for adult congenital heart specialist follow-up.

How similar studies have gone: Previous retrospective work identified long waits and health declines during transfer, and while some transition programs have reduced loss to follow-up in other settings, prospective evidence specific to structured ACHD transfer programs is limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* All new patients with congenital heart disease referred from the pediatric hospital and the community

Exclusion Criteria:

* None

Where it's running

  • University of Ottawa Heart Institute
    Ottawa, Ontario, Canada
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.